Startseite › Nichtkleinzelliges Lungenkarzinom › Washington › Tacoma
Klinische Studien zu Nichtkleinzelliges Lungenkarzinom in Tacoma, WA
20 Studien zu Nichtkleinzelliges Lungenkarzinom suchen Teilnehmer an Standorten in und um Tacoma (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
Teilnehmer gesuchtPhase 3
- Northwest Medical Specialties - Tacoma, Tacoma
- Northwest Medical Specialties - Gig Harbor, Gig Harbor · 8 mi entfernt
- Northwest Medical Specialties - Puyallup Medical Oncology, Puyallup · 8 mi entfernt
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Teilnehmer gesuchtPhase 1/2
- Northwest Medical Specialties Tacoma /ID# 270469, Tacoma
- Vista Oncology - East Olympia /ID# 275438, Olympia · 26 mi entfernt
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Teilnehmer gesuchtPhase 3
- American Oncology Network Vista Oncology Division-West office, Olympia · 26 mi entfernt
- American Oncology Network Vista Oncology Division-East office, Olympia · 26 mi entfernt
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Teilnehmer gesuchtPhase 3
- Vista Oncology Inc PS, Olympia · 26 mi entfernt
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Teilnehmer gesuchtPhase 3
- American Oncology Network Vista Oncology Division-West office, Olympia · 26 mi entfernt
- American Oncology Network Vista Oncology Division-East office, Olympia · 26 mi entfernt
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Teilnehmer gesuchtPhase 2
- Vista Oncology, Olympia · 26 mi entfernt
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Teilnehmer gesuchtPhase 1/2
- Northwest Medical Specialties, Tacoma
Pan-tumor MRD Study
Teilnehmer gesuchtBeobachtungsstudie
- Northwest Medical Specialties (NWMS), Tacoma
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Teilnehmer gesuchtPhase 3
- Local Institution - 0499, Lacey · 23 mi entfernt
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Teilnehmer gesuchtPhase 3
- Research Site, Tacoma
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Teilnehmer gesuchtPhase 2
- Northwest Medical Specialties Tacoma /ID# 270534, Tacoma
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Teilnehmer gesuchtPhase 3
- Research Site, Tacoma
- Research Site, Olympia · 26 mi entfernt
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Teilnehmer gesuchtPhase 2/3
- Vista Oncology - East Olympia /ID# 262303, Olympia · 26 mi entfernt
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Teilnehmer gesuchtPhase 3
- Research Site, Tacoma
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Teilnehmer gesuchtPhase 1
- Northwest Medical Specialties, Tacoma
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Teilnehmer gesuchtPhase 3
- Research Site, Tacoma
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- Exigent Research, LLC, Tacoma
- Northwest Medical Specialities, PLLC, Tacoma
- Northwest Medical Specialities. PLLC, Gig Harbor · 8 mi entfernt
- und 3 weitere
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Teilnehmer gesuchtPhase 3
- MultiCare Institute for Research & Innovation, Tacoma
- MultiCare Regional Cancer Center, Gig Harbor · 8 mi entfernt
- MultiCare Regional Cancer Center, Puyallup · 8 mi entfernt
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Teilnehmer gesuchtPhase 2
- USA09-0, Puyallup · 8 mi entfernt
BostonGene and Exigent Genomic INsight Study
Teilnehmer gesuchtBeobachtungsstudie
- Northwest Medical Specialities, Puyallup · 8 mi entfernt
Nichtkleinzelliges Lungenkarzinom-Studien in anderen Städten
- Houston, TX145 Studien
- New York City, NY120 Studien
- Arlington, VA104 Studien
- Nashville, TN97 Studien
- Boston, MA90 Studien
- Los Angeles, CA87 Studien
- St. Louis, MO73 Studien
- Chicago, IL61 Studien
- Baltimore, MD60 Studien
- San Antonio, TX59 Studien
- Columbus, OH56 Studien
- Washington, DC55 Studien
Weitere Studien in Tacoma
- Brustkrebs18 Studien
- Colitis ulcerosa15 Studien
- Multiples Myelom13 Studien
- Prostatakrebs11 Studien
- Morbus Crohn11 Studien
- Metastasierender Krebs9 Studien
- Kolorektales Karzinom9 Studien
- Melanom7 Studien
- Eierstockkrebs7 Studien
- Krebs (alle Arten)6 Studien
- Bauchspeicheldrüsenkrebs6 Studien
- Adipositas6 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 05.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.